Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction

AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolo...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 14; no. 28; pp. 4462 - 4472
Main Authors Pilvi, Taru-K, Seppanen-Laakso, Tuulikki, Simolin, Helena, Finckenberg, Piet, Huotari, Anne, Herzig, Karl-Heinz, Korpela, Riitta, Oresic, Matej, Mervaala, Eero-M
Format Journal Article
LanguageEnglish
Published United States Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland 28.07.2008
Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland
Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland
Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland
Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland
The WJG Press and Baishideng
Subjects
Online AccessGet full text

Cover

Loading…
Abstract AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57BI/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P 〈 0.001) and serum insulin (P 〈 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and cerarnides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P 〈 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic cerarnides (P 〈 0.001, vs obese; P 〉 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway rnetabolites. CONCLUSION: ER-induced changes on hepatic rnetabolornic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
AbstractList AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57Bl/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. CONCLUSION: ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
R5; AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium.METHODS: Liver metabolomic profile of lean and obese C57BI/6] mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic an alyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform.RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01).In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipidratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control Ergroup, but decreased in the whey + Ca ER group (P< 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P> 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites.CONCLUSION: ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
AIMTo characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODSLiver metabolomic profile of lean and obese C57Bl/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTSER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. CONCLUSIONER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57Bl/6J mice ( n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose ( P < 0.001) and serum insulin ( P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group ( P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides ( P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. CONCLUSION: ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57BI/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P 〈 0.001) and serum insulin (P 〈 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and cerarnides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P 〈 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic cerarnides (P 〈 0.001, vs obese; P 〉 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway rnetabolites. CONCLUSION: ER-induced changes on hepatic rnetabolornic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. Liver metabolomic profile of lean and obese C57Bl/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied.
Author Taru K Pilvi Tuulikki Seppanen-Laakso Helena Simolin Pier Finckenberg Anne Huotari Karl-Heinz Herzig Riitta Korpela Matej Oresic Eero M Mervaala
AuthorAffiliation Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki, Helsinki FI-00390, Finland Foundation for Nutrition Research, PO Box 30, Helsinki FI-00390, Finland; Valio Ltd, Research Center, PO Box 30, Valio, Helsinki FI-00039, Finland VTT Technical Research Centre of Finland, Tietotie 2, VTT FI-02044, Finland A. I. Virtanen Institute for Molecular Sciences, PO Box 1627, University of Kuopio, Kuopio FI-70211, Finland Department of Internal Medicine, Kuopio University Hospital, PO Box 1777, Kuopio FI-70211, Finland; Institute of Biomedicine, Department of Physiology, and Biocenter of Oulu PO Box 5000, University of Oulu, Oulu FI-90014, Finland
AuthorAffiliation_xml – name: Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland;Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland;Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland;Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland;Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland
Author_xml – sequence: 1
  givenname: Taru-K
  surname: Pilvi
  fullname: Pilvi, Taru-K
  organization: University of Helsinki, Helsinki FI-00390, Finland
– sequence: 2
  givenname: Tuulikki
  surname: Seppanen-Laakso
  fullname: Seppanen-Laakso, Tuulikki
– sequence: 3
  givenname: Helena
  surname: Simolin
  fullname: Simolin, Helena
– sequence: 4
  givenname: Piet
  surname: Finckenberg
  fullname: Finckenberg, Piet
– sequence: 5
  givenname: Anne
  surname: Huotari
  fullname: Huotari, Anne
– sequence: 6
  givenname: Karl-Heinz
  surname: Herzig
  fullname: Herzig, Karl-Heinz
– sequence: 7
  givenname: Riitta
  surname: Korpela
  fullname: Korpela, Riitta
– sequence: 8
  givenname: Matej
  surname: Oresic
  fullname: Oresic, Matej
– sequence: 9
  givenname: Eero-M
  surname: Mervaala
  fullname: Mervaala, Eero-M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18680224$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70920$$DView record from Swedish Publication Index
BookMark eNpVkctvEzEQxi1URNPCiTuyEOICCfZ4H_YFqSpPqYgLcLW8fmyc7tqpvdso_z0OiYAerDn4N998M98FOgsxWISeU7JibcXf7Tb9ilarqmrgEVoAULEEXpEztKCEtEvBoD1HFzlvCAHGaniCzilvOAGoFuj2m51UF4c4eo31WoXeZuwDdmqa9njw9zZhrQLuLB6j8c5bg7s9Nr60pT3epjjZgqtgCjZoP4_YzMmHHttgU7_HyeYpeT35GJ6ix04N2T471Uv089PHH9dfljffP3-9vrpZ6qqFaWlYZ1pqLK3B6Ap0p3jFWjC2pkQI0WhX10wDq2vnOg1akdYQ4rhSjQAOhF2it0fdvLPbuZPb5MdiVkbl5Qf_60rG1Jc3y5aIP_j7I17Y0Rptw5TU8KDr4U_wa9nHewkto9DSIvDqKLBTwZULyk2cUygbyhINEMKBE9IU7PVpTop3czmLHH3WdhhUsHHOshFM1A3hBXxzBHWKOSfr_nqhRB4iP-hKWslD5IV-8b_9f-wp4wK8PMmtY-jvSjayU_rW-cGWFQSvRYF-A7_atvQ
CitedBy_id crossref_primary_10_1016_j_idairyj_2021_105269
crossref_primary_10_1155_2011_525094
crossref_primary_10_3390_nu13072451
crossref_primary_10_1016_j_numecd_2009_04_018
crossref_primary_10_1371_journal_pone_0088904
crossref_primary_10_1017_jns_2019_12
crossref_primary_10_1016_j_idairyj_2011_03_006
crossref_primary_10_1186_1476_511X_10_57
crossref_primary_10_1089_omi_2010_0109
crossref_primary_10_1002_oby_20440
crossref_primary_10_1016_j_advnut_2024_100252
crossref_primary_10_1631_jzus_B1400255
crossref_primary_10_1080_10408398_2010_549596
crossref_primary_10_1021_acs_jproteome_6b00336
crossref_primary_10_1111_apha_12436
crossref_primary_10_5851_kosfa_2015_35_5_653
Cites_doi 10.1053/j.gastro.2007.03.055
10.1016/j.bbalip.2007.07.007
10.1093/jn/134.11.3054
10.1016/j.plipres.2005.11.002
10.1161/ATVBAHA.107.147538
10.1016/S0163-7827(01)00020-0
10.2337/dc06-0256
10.1002/hep.21763
10.1186/1752-0509-1-12
10.1093/ajcn/22.9.1161
10.1016/S0531-5565(02)00202-4
10.2337/db07-0111
10.1136/jech.2006.053157
10.1136/jech.2006.052126
10.1093/bioinformatics/btk039
10.1038/oby.2003.52
10.1017/S0007114507764760
10.1096/fj.00-0584fje
10.1001/archinte.165.9.997
10.2337/diacare.24.10.1758
10.1152/ajpendo.1999.277.2.E352
10.1038/sj.ijo.0802880
10.1016/j.jnutbio.2007.01.009
10.2217/14622416.7.7.1077
10.1186/1471-2105-6-179
10.1194/jlr.R600022-JLR200
10.1016/S0014-5793(00)01950-5
10.1080/07315724.2005.10719502
10.1093/ajcn/82.3.523
10.1371/journal.pgen.0030064
10.1016/B978-012330215-1/50008-9
10.1001/jama.287.16.2081
10.1074/jbc.M406499200
10.1371/journal.pone.0000097
10.1080/07853890510037383
10.1038/oby.2005.144
10.1073/pnas.0707060104
10.2337/diacare.28.12.2926
10.1093/ajcn/86.2.285
10.1152/physiolgenomics.00084.2006
ClassificationCodes R5
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
2008 The WJG Press and Baishideng. All rights reserved. 2008
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: 2008 The WJG Press and Baishideng. All rights reserved. 2008
DBID 2RA
92L
CQIGP
W91
~WA
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
2B.
4A8
92I
93N
PSX
TCJ
5PM
AABEP
ADTPV
AOWAS
D8T
D91
ZZAVC
DOI 10.3748/wjg.14.4462
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
SWEPUB Örebro universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Örebro universitet
SwePub Articles full text
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction
EISSN 2219-2840
EndPage 4472
ExternalDocumentID oai_DiVA_org_oru_70920
wjg200828006
10_3748_wjg_14_4462
18680224
27985924
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Foundation for Nutrition Research, Academy of Finland, Sigrid Juselius Foundation and Valio Ltd., Helsinki,Finland
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CDYEO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
W91
WFFXF
XSB
~WA
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
4A8
PSX
5PM
AABEP
ADTPV
AOWAS
D8T
D91
ZZAVC
ID FETCH-LOGICAL-c472t-d3bd71de152dc42cba84372de5109996cf553c2355ffbc2ca07d00f8aa6928203
IEDL.DBID RPM
ISSN 1007-9327
2219-2840
IngestDate Sat Aug 24 00:16:22 EDT 2024
Thu Aug 31 06:35:47 EDT 2023
Wed Nov 06 04:37:42 EST 2024
Fri Oct 25 09:17:25 EDT 2024
Fri Aug 23 03:59:57 EDT 2024
Wed Oct 16 00:47:27 EDT 2024
Fri Nov 25 02:42:07 EST 2022
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 28
Keywords Energy restriction
Metabolomics
Dietary calcium
Fatty liver
Whey protein
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-d3bd71de152dc42cba84372de5109996cf553c2355ffbc2ca07d00f8aa6928203
Notes Energy restriction
Metabolomics
Fatty liver
14-1219/R
Fatty liver; Metabolomics; Energy restriction; Whey protein; Dietary calcium
Dietary calcium
R575.5
Whey protein
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Fax: +358-9-19125364
Correspondence to: Eero M Mervaala, MD, Professor, Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, University of Helsinki, Helsinki FI-00390, Finland. eero.mervaala@helsinki.fi
Author contributions: Pilvi TK designed and conducted the study, analysed the data and prepared the manuscript. Seppänen-Laakso T, Simolin H and Orešič M did the metabolomic analyses. Huotari A and Herzig KH conducted the metabolic performance and calorimetry tests. Korpela R and Mervaala EM were involved in designing the study, reviewing and interpreting the results and all authors were involved in drafting the manuscript.
Telephone: +358-9-19125355
OpenAccessLink https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70920
PMID 18680224
PQID 69395608
PQPubID 23479
PageCount 11
ParticipantIDs swepub_primary_oai_DiVA_org_oru_70920
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2731271
wanfang_journals_wjg200828006
proquest_miscellaneous_69395608
crossref_primary_10_3748_wjg_14_4462
pubmed_primary_18680224
chongqing_backfile_27985924
PublicationCentury 2000
PublicationDate 2008-07-28
PublicationDateYYYYMMDD 2008-07-28
PublicationDate_xml – month: 07
  year: 2008
  text: 2008-07-28
  day: 28
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationTitle_FL WORLD JOURNAL OF GASTROENTEROLOGY
PublicationYear 2008
Publisher Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland
Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland
Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland
Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland
Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland
The WJG Press and Baishideng
Publisher_xml – name: Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland
– name: Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland
– name: Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland
– name: Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland
– name: Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland
– name: The WJG Press and Baishideng
References ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref42
ref41
ref22
ref21
ref43
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
References_xml – ident: ref4
  doi: 10.1053/j.gastro.2007.03.055
– ident: ref36
  doi: 10.1016/j.bbalip.2007.07.007
– ident: ref20
  doi: 10.1093/jn/134.11.3054
– ident: ref33
  doi: 10.1016/j.plipres.2005.11.002
– ident: ref2
  doi: 10.1161/ATVBAHA.107.147538
– ident: ref37
  doi: 10.1016/S0163-7827(01)00020-0
– ident: ref10
  doi: 10.2337/dc06-0256
– ident: ref5
  doi: 10.1002/hep.21763
– ident: ref6
  doi: 10.1186/1752-0509-1-12
– ident: ref42
  doi: 10.1093/ajcn/22.9.1161
– ident: ref43
– ident: ref39
  doi: 10.1016/S0531-5565(02)00202-4
– ident: ref7
  doi: 10.2337/db07-0111
– ident: ref13
  doi: 10.1136/jech.2006.053157
– ident: ref12
  doi: 10.1136/jech.2006.052126
– ident: ref27
  doi: 10.1093/bioinformatics/btk039
– ident: ref24
  doi: 10.1038/oby.2003.52
– ident: ref22
  doi: 10.1017/S0007114507764760
– ident: ref18
  doi: 10.1096/fj.00-0584fje
– ident: ref11
  doi: 10.1001/archinte.165.9.997
– ident: ref1
  doi: 10.2337/diacare.24.10.1758
– ident: ref40
  doi: 10.1152/ajpendo.1999.277.2.E352
– ident: ref30
– ident: ref16
  doi: 10.1038/sj.ijo.0802880
– ident: ref19
  doi: 10.1016/j.jnutbio.2007.01.009
– ident: ref32
  doi: 10.2217/14622416.7.7.1077
– ident: ref28
  doi: 10.1186/1471-2105-6-179
– ident: ref31
  doi: 10.1194/jlr.R600022-JLR200
– ident: ref41
  doi: 10.1016/S0014-5793(00)01950-5
– ident: ref21
  doi: 10.1080/07315724.2005.10719502
– ident: ref23
– ident: ref15
  doi: 10.1093/ajcn/82.3.523
– ident: ref26
  doi: 10.1371/journal.pgen.0030064
– ident: ref25
  doi: 10.1016/B978-012330215-1/50008-9
– ident: ref9
  doi: 10.1001/jama.287.16.2081
– ident: ref34
  doi: 10.1074/jbc.M406499200
– ident: ref29
  doi: 10.1371/journal.pone.0000097
– ident: ref3
  doi: 10.1080/07853890510037383
– ident: ref17
  doi: 10.1038/oby.2005.144
– ident: ref35
  doi: 10.1073/pnas.0707060104
– ident: ref14
  doi: 10.2337/diacare.28.12.2926
– ident: ref8
  doi: 10.1093/ajcn/86.2.285
– ident: ref38
  doi: 10.1152/physiolgenomics.00084.2006
SSID ssj0023352
Score 2.0469418
Snippet AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated...
To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether...
AIMTo characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated...
R5; AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also...
AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated...
SourceID swepub
pubmedcentral
wanfang
proquest
crossref
pubmed
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 4462
SubjectTerms Animals
Basic Research
Blood Glucose - metabolism
Body Weight - drug effects
Body Weight - physiology
Calcium, Dietary - pharmacology
dietary calcium
Dietary Proteins - pharmacology
Disease Models, Animal
Energy Metabolism - physiology
energy restriction
Fatty liver
Fatty Liver - metabolism
Fatty Liver - physiopathology
Insulin - blood
Lipid Metabolism - drug effects
Lipid Metabolism - physiology
Liver - metabolism
Liver - pathology
Male
metabolomics
Mice
Mice, Inbred C57BL
whey protein
能量限制
脂肪肝
蛋白质
钙离子
饮食调节
Title Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction
URI http://lib.cqvip.com/qk/84123X/200828/27985924.html
https://www.ncbi.nlm.nih.gov/pubmed/18680224
https://search.proquest.com/docview/69395608
https://d.wanfangdata.com.cn/periodical/wjg200828006
https://pubmed.ncbi.nlm.nih.gov/PMC2731271
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70920
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB21PXFBIL5CKfhQjtnNOh92jlVLVSEt4kBRb5Y_t6G7TtnNCu2_79hJCqveiJRTnMjyczzz5HnPAKelM6biSqaYW-i0qK1Ka81NWmlVlo47OYteevNv1dV18fWmvDmActTCxKJ9rZqJX64mvrmNtZX3Kz0d68Sm3-fnGHJnlM2mh3CIE3Sk6APLCiKiuMWZsRSTE9aL8oLLyvTPrwWuDBNkQPEQG14FnWkRXBVuW7_4jbFiPzo9STmfVk4O_qJR8uOd9It_otPlC3g-pJXkrO_-Sziw_hXczW2HGC-D8Jj0Ct8NaTxxsut2ZBkqMgiOLFGWrFrTOMxGidoR0-Br6x2JFg7YXHqDzZa62a5Ir2okNioGSTjXY91EZcRruL788uP8Kh0OV0h1wWiXmlwZNjMW47fRBdVK8rCFZ2wZ9srqSruyzDXFdMQ5pamWGTNZ5riUVY00LcvfwJFvvX0HpNbK1JVymY0ERuHFubPBuD1nmXIJHD8OMAZnfRcspwRlNS-R_SVwOg65uO8dNgQykwCYQMCQm4gAWAKfRjgE_gFhW0N62243oqrzQPJ4Am97cP5-ZkA4AbYH22OD4K29_wSnXPTYHqZYAp97gPdeuWh-nol2vcB7K1hW0yyBkwF_MawBm9B5Gh0CcWF7_989OIZnfYkKSyn_AEfdemtPMA_q1Mc47x8AVCILKQ
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VcoALAvEVSqkP5ZjdbL7sHKtCtUC34tCi3ix_bkN3nbKbFdp_z9hJCqveiJRTnCjxiz3z5HnPAMeF1bpkUsSYW6g4r4yMK8V0XCpZFJZZMQleerOLcnqVf70urvegGLQwoWhfyXrkFsuRq29CbeXdUo2HOrHx99kphtxJSifjR_AYx2uSDyS951leRhQWORMaY3pCO1me91kZ__45x7lhhBwobGPDSq80zb2vwk3j5r8wWuzGpwdJ58Payd5hNIh-nBVu_k98OnsOz_rEkpx0H_AC9ox7Cbcz0yLKCy89Jp3Gd01qR6xo2y1Z-JoMgn1LpCHLRtcW81Eit0TXeNtqS4KJAzYXTmOzhao3S9LpGokJmkHid_ZY1UEb8Qquzj5fnk7jfnuFWOU0bWOdSU0n2mAE1ypPlRTML-JpU_jVsqpUtigylWJCYq1UqRIJ1UlimRBlhUQtyV7DvmuceQukUlJXpbSJCRRG4sGYNd66PaOJtBEc3Hcwhmd1602neEorViD_i-B46HJ-13lscOQmHjCOgCE74R6wCI4GODiOAb-wIZxpNmteVpmneSyCNx04fx_TIxwB3YHtvoF31969gj9dcNnuf7IIPnYA79zyqf5xwpvVHM8Np0mVJhEc9vjzfhZY-5dPg0cgTm3v_vsNjuDJ9HJ2zs-_XHw7gKddwQqNU_Ye9tvVxhxiVtTKD2EM_AGCWA5_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswFCTaFCh6KVp0U7PxkB5l0dpIHYMkRpLWQQ5NkRvB1VFjU64tI_Df95GS0xi5VYBOogSJI_K9Ad8METoqrNYlkyKG3ELFeWVkXCmm41LJorDMimHw0htflec3-eVtcftkq69QtK9kPXDT2cDVd6G2cj5TyaZOLLken0DIHaZ0mMy1TV6iVzBmSbkh6j3X8lKisNBJaAwpCu2ked5rJXn4PYH5YQA8KGxlw0qvNs29t8Jd4yZ_IGJsx6hniefz-sneZTQIf5wVbvIkRo3eobd9comPu494j14Y9wHdj00LSE-9_Bh3Ot8lrh22om3XeOrrMjD0L5YGzxpdW8hJsVxjXcNtizUORg7QXDgNzaaqXs1wp23EJugGsd_dY1EHfcRHdDM6-3lyHvdbLMQqp2kb60xqOtQGorhWeaqkYH4hT5vCr5hVpbJFkakUkhJrpUqVIFQTYpkQZQVkjWSf0I5rnPmCcKWkrkppiQk0RsLBmDXevj2jRNoI7T52MIRode-Np3hKK1YAB4zQ0abL-bzz2eDATzxgHAADhsI9YBE63MDBYRz4xQ3hTLNa8rLKPNVjEfrcgfPvMT3CEaJbsD028A7b21fgxwtO2_2PFqFvHcBbt5zWv455s5jAueKUVCmJ0H6PP-9ngqV_-TT4BML09vW_3-AQvb4-HfEfF1ffd9GbrmaFxinbQzvtYmX2ITFq5UEYAn8BVh8Pkg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolomic+changes+in+fatty+liver+can+be+modified+by+dietary+protein+and+calcium+during+energy+restriction&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Taru+K+Pilvi+Tuulikki+Seppanen-Laakso+Helena+Simolin+Pier+Finckenberg+Anne+Huotari+Karl-Heinz+Herzig+Riitta+Korpela+Matej+Oresic+Eero+M+Mervaala&rft.date=2008-07-28&rft.issn=1007-9327&rft.eissn=2219-2840&rft.volume=14&rft.issue=28&rft.spage=4462&rft.epage=4472&rft_id=info:doi/10.3748%2Fwjg.14.4462&rft.externalDocID=27985924
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fwjg%2Fwjg.jpg